Six months ago, Omega Ophthalmics did a small trial of seven patients outside of the US. Their goal was to test for adverse effects of a surgery similar to lens replacements that often accompany cataract removals. The difference? Rather than replacing the cloudy lens with a normal artificial lens, surgeons instead implanted a lens that could be used for augmented reality, interactive sensors, or drug delivery.
Why it’s hot
Although widespread adoption of this technology is unlikely in the near future, scientists, entrepreneurs, and venture capitalists hope that there is a market for such implants in an aging population that wants to be independent for longer. Whether this small trial is successful may pave the way for larger trials to test additional possibilities and risk.
Learn more at TechCrunch.com